touchPODCAST
Treatment sequencing and the benefits of disease-modifying therapies in multiple sclerosis

Treatment sequencing and the benefits of disease-modifying therapies in multiple sclerosis

June 30, 2022

Listen to Prof. Gavin Giovannoni, in discussion with Prof. Eva Havrdová and Prof. Dr Patrick Vermersch, on the benefits of disease-modifying therapies in multiple sclerosis, and current approaches to treatment sequencing. 


Part 1:  Towards effective and meaningful monitoring of disease activity in multiple sclerosis

Part 2: Optimizing individualized management in an expanding therapeutic landscape

Part 3: Safety and immunologic considerations associated with disease modifying therapies

 

This touchPODCAST is for HCPs only. Funding for this touchPODCAST from an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstat. The content was led by touchIME.

Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer

Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer

June 15, 2022

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer.

The experts

  • Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil
  • Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany
  • Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/

How can real-world evidence guide the management of elderly and frail patients with multiple myeloma?

How can real-world evidence guide the management of elderly and frail patients with multiple myeloma?

June 13, 2022

touchIN CONVERSATION for touchONCOLOGY

Listen to Dr Randy Broun, a community oncologist and haematologist, in conversation with Dr Faith Davies, a multiple myeloma expert. They respond to questions submitted by the HCP audience and provide their expert insights on how real-world evidence can guide the management of elderly and frail patients with multiple myeloma.

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Takeda Pharmaceuticals USA Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: www.touchoncology.com

Navigating the challenges of treatment provision in recurrent/metastatic HNSCC

Navigating the challenges of treatment provision in recurrent/metastatic HNSCC

May 26, 2022

touchPANEL DISCUSSION for touchONCOLOGY

Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.

The experts

  • Prof. Lisa Licitra - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
  • Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil
  • Prof. Joël Guigay - Cancer Center Antoine Lacassagne, Nice, France

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/

Managing EoE: What options are emerging for patients? - Conversation 3

Managing EoE: What options are emerging for patients? - Conversation 3

May 24, 2022

touchMDT for touchIMMUNOLOGY

Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.

The multidisciplinary team

  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
  • Dietitian: Dr Isabel Skypala, UK

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

Symptoms of EoE: What is the burden for patients? - Conversation 2

Symptoms of EoE: What is the burden for patients? - Conversation 2

May 24, 2022

touchMDT for touchIMMUNOLOGY

Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.

The multidisciplinary team 

  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Dietitian: Dr Isabel Skypala, UK

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

Pathophysiology of EoE: What do we see in patients? - Conversation 1

Pathophysiology of EoE: What do we see in patients? - Conversation 1

May 24, 2022

touchMDT for touchIMMUNOLOGY

Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. 

The multidisciplinary team

  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/mdt-improving-outcomes-in-eoe/

Managing EoE: What options are emerging for patients? - Conversation 3

Managing EoE: What options are emerging for patients? - Conversation 3

May 24, 2022

touchMDT for touchRESPIRATORY

Listen to leading experts engage in a case-based discussion on the management of EoE, covering both current practice and therapeutic options on the horizon.

The multidisciplinary team

  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
  • Dietitian: Dr Isabel Skypala, UK

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/

Symptoms of EoE: What is the burden for patients? Conversation 2

Symptoms of EoE: What is the burden for patients? Conversation 2

May 24, 2022

touchMDT for touchRESPIRATORY

Listen to a multidisciplinary team of experts as they explore the symptoms of EoE and their impact on patients in a case-based discussion of an adult newly presenting with food impaction.

The multidisciplinary team 

  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands
  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Dietitian: Dr Isabel Skypala, UK

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This activity is jointly provided by USF Health and touchIME. 

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/

Pathophysiology of EoE What do we see in patients - Conversation 1

Pathophysiology of EoE What do we see in patients - Conversation 1

May 24, 2022

touchMDT for touchRESPIRATORY

Listen to leading experts discuss the environmental, genetic and immunological factors that contribute to the development of eosinophilic oesophagitis. 

The multidisciplinary team

  • Allergist/immunologist: Prof. Jonathan Spergel, USA
  • Gastroenterologist: Prof. Arjan Bredenoord, The Netherlands

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi. This medical education is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchrespiratoryime.org/mdt-improving-outcomes-in-eoe/

Podbean App

Play this podcast on Podbean App